1. Gastric hepatoid adenocarcinoma: a computed tomography report of six cases.
- Author
-
Ren A, Cai F, Shang YN, Ma ES, Huang ZG, Wang W, and Luo J
- Subjects
- Adenocarcinoma blood, Adenocarcinoma classification, Adenocarcinoma secondary, Adenocarcinoma therapy, Aged, Biopsy, Fatal Outcome, Female, Humans, Immunohistochemistry, Liver Neoplasms classification, Liver Neoplasms secondary, Liver Neoplasms therapy, Lymphatic Metastasis, Male, Middle Aged, Predictive Value of Tests, Prognosis, Receptors, Peptide blood, Stomach Neoplasms blood, Stomach Neoplasms classification, Stomach Neoplasms pathology, Stomach Neoplasms therapy, Terminology as Topic, Time Factors, Adenocarcinoma diagnostic imaging, Liver Neoplasms diagnostic imaging, Stomach Neoplasms diagnostic imaging, Tomography, X-Ray Computed
- Abstract
We describe the computed tomography (CT) imaging findings in six cases (five males and one female; age range 61-78 years; mean age 67.3 years) with histologically proven hepatoid adenocarcinoma of the stomach (HAS). Five of the six patients had elevated serum alpha-fetoprotein levels. The most common type of gross appearance HAS on CT is a polypoid mass (83%, 5/6). The most common contrast enhancement pattern was heterogeneous. All six patients had a regional lymphadenopathy larger than 6 mm in its short axis. Liver metastases (n = 3) were noted. Venous tumor thrombosis was identified in the portal vein (n = 2) of the regions near primary gastric tumors or metastatic masses. Our findings suggest in an elderly, male patients with a large heterogeneous enhancement tumor, the presence of distant metastases, regional lymphadenopathy and characteristically increased serum alpha-fetoprotein levels indicates a high likelihood of HAS.
- Published
- 2014
- Full Text
- View/download PDF